JPM's Lomer: 2016 a 'Vintage Year' to Invest in U.K.

The video discusses the economic outlook for 2017, highlighting key challenges and resilience in M&A activities during 2016. It explores industry-specific M&A trends, particularly in pharmaceuticals, biotech, TMT, and healthcare. The discussion also covers factors influencing M&A decisions, emphasizing CEO perspectives on growth opportunities. Finally, it examines the UK market's investment potential amid currency fluctuations and reduced inbound activity.

What were some of the significant challenges faced by the M&A market in 2016?

• Lack of pharmaceutical deals

• Stable oil prices

• Chinese growth concerns and Brexit

• High GDP growth

Which industries were notably active in M&A during 2016?

• Automotive and retail

• Pharmaceuticals and biotech

• Agriculture and mining

• Real estate and construction

What is a key driver for M&A activities according to the second section?

• Lack of competition

• Government incentives

• Strategic fundamentals and growth opportunities

• High interest rates

Which sector is expected to see more M&A activity due to fundamental changes?

• Tourism

• Education

• Oil and gas

• Retail

What factor is influencing the perception of UK investments as a potential opportunity?

• Increased domestic demand

• Falling pound

• Stable political environment

• Rising interest rates